A Study of DII235 in Adults With Elevated Lipoprotein(a)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 234 participants.
Also called NCT07235046
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 234 participants
- Sponsor
- Registry
-
NCT07235046
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, China, Germany, Japan
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT07235046. Randomized; double masking; primary purpose treatment. Start 2025-12-02 (actual); primary completion 2027-04-26 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of DII235 in Adults With Elevated Lipoprotein(a)
- Condition
- Lipoprotein Disorder
- Intervention (Drug)
- DII235
- Intervention (Drug)
- Saline
- Lead sponsor
- Novartis Pharmaceuticals
Record details
- Record id
cardio:ct-nct07235046- Content hash
4a13cd82c3724bfe081d188982cecf156ea7855fb0270d2e0144cafc2ec9a652